New-York-based Perk-Up is recalling 114,540 pounds of chicken-based products that were “ineligible” for import, US safety officials have announced.


The US Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced the recall on Friday (3 April) due to the products not meeting inspection or poultry exemption requirements.


It could not be determined that the poultry ingredients used in the chicken base products were prepared under inspection, as required by federal regulations, or under an eligible foreign inspection system determined to be equivalent.


The poultry ingredient is determined to be ineligible when the source of the ingredients cannot be found.


The products subject to recall include: 5lb pails of Panda brand Chicken Base Concentrado de Caldo de Pollo with case code 2700031, and 5lb bags of the same product with case code 2700200.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The chicken base products were imported from China on various dates from May 2008 to September 2008 and were sent to distribution establishments nationwide.


The problem was discovered after FSIS personnel identified the chicken-base products in the marketplace.


FSIS said it has received no reports of illnesses in relation to consumption of the product.